We are live on ! Find out more
GCA

Greenwood Capital Associates Portfolio holdings

AUM $1.02B
1-Year Est. Return 28.26%
This Fund
S&P 500
This Quarter Est. Return
+11.02%
1 Year Est. Return
+28.26%
3 Year Est. Return
+81.29%
5 Year Est. Return
+95.78%
10 Year Est. Return
+421.94%
AUM
$772M
AUM Growth
+$83.7M
Cap. Flow
+$20M
Cap. Flow %
2.59%
Top 10 Hldgs %
23.79%
Holding
277
New
30
Increased
91
Reduced
113
Closed
31

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$8.37M
2
UNH icon
UnitedHealth
UNH
+$6.9M
3
SYK icon
Stryker
SYK
+$5.97M
4
AMZN icon
Amazon
AMZN
+$5.71M
5
NVO
Novo Nordisk
NVO
+$4.09M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$6.39M
2
NXPI icon
NXP Semiconductors
NXPI
+$5.81M
3
ABT icon
Abbott
ABT
+$5.43M
4
SPLK
Splunk Inc
SPLK
+$5.14M
5
HOLX
Hologic
HOLX
+$5.09M

Sector Composition

Rank Sector Weight
1 Technology 21.16%
2 Healthcare 14.53%
3 Financials 8.29%
4 Industrials 8.18%
5 Communication Services 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GMED icon
201
Globus Medical
GMED
$11.5B
$439K 0.06%
8,242
-155
-2% -$7.55K
UBSI icon
202
United Bankshares
UBSI
$6.66B
$434K 0.06%
+11,568
New +$368K
CRSP icon
203
CRISPR Therapeutics
CRSP
$5.22B
$426K 0.06%
6,801
+1,306
+24% +$72.2K
PG icon
204
Procter & Gamble
PG
$335B
$425K 0.06%
2,902
-261
-8% -$38.7K
LSCC icon
205
Lattice Semiconductor
LSCC
$18.4B
$423K 0.05%
6,132
-5,223
-46% -$347K
WRB icon
206
W.R. Berkley
WRB
$25.9B
$420K 0.05%
+8,898
New +$406K
SSB icon
207
SouthState Bank Corp
SSB
$10.7B
$404K 0.05%
4,779
-846
-15% -$62.5K
HCKT icon
208
Hackett Group
HCKT
$278M
$403K 0.05%
17,699
-374
-2% -$8.48K
CAT icon
209
Caterpillar
CAT
$393B
$400K 0.05%
+1,352
New +$351K
MU icon
210
Micron Technology
MU
$1.03T
$397K 0.05%
4,652
– –
SPHB icon
211
Invesco S&P 500 High Beta ETF
SPHB
$947M
$394K 0.05%
+4,784
New +$345K
EFV icon
212
iShares MSCI EAFE Value ETF
EFV
$30.1B
$389K 0.05%
7,463
– –
PRK icon
213
Park National Corp
PRK
$3.72B
$374K 0.05%
2,815
+75
+3% +$8.33K
CCRD
214
DELISTED
CoreCard
CCRD
$370K 0.05%
26,779
-427
-2% -$7.14K
JYNT icon
215
The Joint Corp
JYNT
$123M
$370K 0.05%
38,520
-848
-2% -$7.35K
GEN icon
216
Gen Digital
GEN
$17.1B
$366K 0.05%
16,031
-2,735
-15% -$54.2K
AXP icon
217
American Express
AXP
$232B
$359K 0.05%
1,918
-22,123
-92% -$3.56M
LNTH icon
218
Lantheus
LNTH
$6.57B
$354K 0.05%
+5,709
New +$387K
IXG icon
219
iShares Global Financials ETF
IXG
$698M
$335K 0.04%
4,264
– –
HD icon
220
Home Depot
HD
$342B
$318K 0.04%
917
-255
-22% -$79K
BMY icon
221
Bristol-Myers Squibb
BMY
$130B
$303K 0.04%
5,911
-790
-12% -$41.5K
IWM icon
222
iShares Russell 2000 ETF
IWM
$82.2B
$298K 0.04%
+1,484
New +$266K
VMC icon
223
Vulcan Materials
VMC
$36.3B
$294K 0.04%
1,296
– –
WSM icon
224
Williams-Sonoma
WSM
$28.9B
$294K 0.04%
2,910
– –
CWI icon
225
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.87B
$280K 0.04%
10,366
-889
-8% -$22.6K
7 8
9
10 11

Similar funds

SVCP
Silicon Valley Capital Partners San Jose, California $1.02B AUM 21.85% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $1.02B AUM
CC
Crosslink Capital Menlo Park, California $1.02B AUM 9.21% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return
GA
GRS Advisors Chicago, Illinois $1.01B AUM 13.12% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Greenwood Capital Associates's Q4 2023 Portfolio in Review

As of Q4 2023, Greenwood Capital Associates held 277 positions worth $772M, up 12% from $688M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Greenwood Capital Associates's Q4 2023 filing shows 30 new, 91 increased, 113 reduced and 31 closed positions. Its largest new stake was UnitedHealth: 12,932 shares worth $6.81M. The largest sale was Thermo Fisher Scientific, an estimated $6.39M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Greenwood Capital Associates's largest Q4 2023 buy was UnitedHealth: 12,932 shares worth $6.81M.
  • Greenwood Capital Associates added most to Berkshire Hathaway Class B in Q4 2023, an estimated $8.37M increase.
  • Greenwood Capital Associates's biggest Q4 2023 reduction was Thermo Fisher Scientific, cutting an estimated $6.39M.
  • Greenwood Capital Associates fully exited NXP Semiconductors in Q4 2023, selling an estimated $5.81M.
  • Greenwood Capital Associates's ten largest holdings make up 24% of its $772M portfolio in Q4 2023.
  • Greenwood Capital Associates opened 30 new positions and closed 31 in Q4 2023.
  • Greenwood Capital Associates's portfolio value rose 12% quarter-over-quarter to $772M.

Based on Greenwood Capital Associates's 13F filing for Q4 2023, filed 5 Mar 2024.